Global Breast Imaging Market, by Technology (Ionizing Breast Imaging {Mammography, Positron Emission Tomography-Computed Tomography (PET-CT), Molecular Breast Imaging (MBI)}, Non-ionizing Breast Imaging {Ultrasound, MRI, Image-guided breast biopsy}, and others); by end user (hospitals, diagnostic centres and others (specialty clinics, ambulatory surgical centres, etc.), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 3,905.2 Mn in 2022 and is expected to exhibit a CAGR of 7.6% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Increase in demand of advanced breast imaging products is likely augment growth of market. For instance, newer types of techniques are developed for breast imaging such as 3D mammography. Abbreviated breast MRI is a newer technique that is used with a standard breast MRI scanner. In October 2021, Delphinus Medical Technologies, Inc. one of the leaders in advanced ultrasound development announced that it has received premarket approval (PMA) from U.S. Food and Drug Administration (FDA) for its SoftVue 3D Whole Breast Ultrasound Tomography System (SoftVue).
Global Breast Imaging Market – Impact of Coronavirus (COVID-19) Pandemic
The unexpected breakout of the COVID-19 pandemic has negative impact on the pharmaceutical and life sciences industries. COVID-19 has affected the diagnosis of breast cancer. Rapid increase in COVID-19 cases led to cancellation and rescheduling of appointments associated with breast imaging. In some countries, breast screening and diagnosis was stopped at hospitals and thereby restrain the growth of market.
Browse 34 Market Data Tables and 27 Figures spread through 202 Pages and in-depth TOC on “Global Breast Imaging Market”- Forecast to 2030, Global Breast Imaging Market, by Technology (Ionizing Breast Imaging {Mammography, Positron Emission Tomography-Computed Tomography (PET-CT), Molecular Breast Imaging (MBI)}, Non-ionizing Breast Imaging {Ultrasound, MRI, Image-guided breast biopsy}, and others); by end user (hospitals, diagnostic centres and others (specialty clinics, ambulatory surgical centres, etc.) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/breast-imaging-market-2040
Increasing adoption of inorganic growth strategies by key players is expected to drive growth of market. In January 2021, Smart Breast Corporation, a privately held company with headquarters near Pittsburgh announced the acquisition of certain molecular breast imaging (MBI) assets from Dilon Technologies, Inc.
Key Takeaways of the Global Breast Imaging Market:
- Global breast imaging market is expected to exhibit a CAGR of 7.6% during the forecast period. Increase in awareness about innovative products for breast cancer diagnosis is expected to drive growth of the market.
- Among technology, ionizing breast imaging segment is expected to exhibit the highest CAGR in the global breast imaging market over the forecast period. Promising technology such as mammography, positron emission tomography-computed tomography (PET-CT) for breast imaging is expected to drive growth of segment.
- Among end user, diagnostic centres segment is expected to exhibit higher CAGR in the global breast imaging Availability of services at diagnostics centers is likely drive growth of segment
- Among regions, Asia Pacific is expected to exhibit the highest CAGR in the global breast imaging market. Increase in government initiatives to increase awareness regarding women’s health and increase in focus on enhancing the health care infrastructure is likely drive the growth of market in region.
- Major players operating in the global Breast Imaging market include GE Healthcare, Siemens Healthcare GmbH, Seno Medical, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Hologic, Inc., Aurora Imaging Technologies, Inc., Canon Inc., Dilon Technologies, Inc., Leica Biosystems Nussloch GmbH (Danaher), Carestream Health, Avante Health Solutions, Hitachi, Ltd, PLANMED OY, and Barco
